Instylla Initiates Commercial Launch with First Use of the Embrace™ Hydrogel Embolic System
PR Newswire —
Milestone marks the commercial use of the first and only liquid embolic approved for hypervascular tumor embolization supported by a prospective, randomized, controlled clinical trial BEDFORD, Mass., Jan. 28, 2026 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel...